Self-Amplifying RNA: Advantages and Challenges of a Versatile Platform for Vaccine Development
- PMID: 40285008
- PMCID: PMC12031284
- DOI: 10.3390/v17040566
Self-Amplifying RNA: Advantages and Challenges of a Versatile Platform for Vaccine Development
Abstract
Self-amplifying RNA is synthetic nucleic acid engineered to replicate within cells without generating viral particles. Derived from alphavirus genomes, saRNA retains the non-structural elements essential for replication while replacing the structural elements with an antigen of interest. By enabling efficient intracellular amplification, saRNA offers a promising alternative to conventional mRNA vaccines, enhancing antigen expression while requiring lower doses. However, this advantage comes with challenges. In this review, we highlight the key limitations of saRNA technology and explore potential strategies to overcome them. By identifying these challenges, we aim to provide insights that can guide the future design of saRNA-based therapeutics, extending their potential beyond vaccine applications.
Keywords: VEEV; alphavirus; delivery; limitations; mRNA; saRNA; safety; vaccine.
Conflict of interest statement
T.V. and M.V. are employed by A*STAR Infectious Diseases Labs (A*IDL).
Figures
Similar articles
-
The advent of clinical self-amplifying RNA vaccines.Mol Ther. 2025 Jun 4;33(6):2565-2582. doi: 10.1016/j.ymthe.2025.03.060. Epub 2025 Apr 3. Mol Ther. 2025. PMID: 40186353 Review.
-
The Potential of Extracellular Vesicle-Mediated Spread of Self-Amplifying RNA and a Way to Mitigate It.Int J Mol Sci. 2025 May 26;26(11):5118. doi: 10.3390/ijms26115118. Int J Mol Sci. 2025. PMID: 40507927 Free PMC article.
-
Co-expression of HSV-1 ICP34.5 enhances the expression of gene delivered by self-amplifying RNA and mitigates its immunogenicity.FEBS Open Bio. 2025 Jul;15(7):1079-1089. doi: 10.1002/2211-5463.70036. Epub 2025 Apr 9. FEBS Open Bio. 2025. PMID: 40200732 Free PMC article.
-
Nucleic Acid Nanocapsules as a New Platform to Deliver Therapeutic Nucleic Acids for Gene Regulation.Acc Chem Res. 2025 Jul 1;58(13):1951-1962. doi: 10.1021/acs.accounts.5c00126. Epub 2025 Jun 9. Acc Chem Res. 2025. PMID: 40491030
-
Trans-Amplifying RNA: A Journey from Alphavirus Research to Future Vaccines.Viruses. 2024 Mar 25;16(4):503. doi: 10.3390/v16040503. Viruses. 2024. PMID: 38675846 Free PMC article. Review.
Cited by
-
Next-Generation Vaccine Platforms: Integrating Synthetic Biology, Nanotechnology, and Systems Immunology for Improved Immunogenicity.Vaccines (Basel). 2025 May 30;13(6):588. doi: 10.3390/vaccines13060588. Vaccines (Basel). 2025. PMID: 40573919 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources